© 1985 Oxford University Press
research-article |
Induction of papillomas with a high probability of conversion to malignancy
1Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute Bethesda, MD 20205
2Microbiological Associates, Inc. Bethesda, MD 20816, USA
Papillomas induced by standard initiation-promotion protocols progress to carcinomas at a low frequency. Experimental protocols were developed to elicit papillomas with a higher probability of malignant conversion. SENCAR mice initiated by 7,12-dimethylbenz[a]anthracene were promoted by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) for 5, 10, 20 or 40 weeks. With promotion for 10 weeks or more, a peak of papilloma incidence at 16–20 weeks was followed by a 35–40% decrease within 3 months. A much lower papilloma reponse was seen in mice promoted for 5 weeks, but these papillomas persisted. The yield of malignant tumors was similar in all four groups, with 20–25 carcinomas per group of 30 mice.Thus, the papillomas induced by the first few TPA treatments are much more likely to progress to carcinomas than those which appear later. In a separate study, initiated Charles River CD-1 mice were promoted with TPA for either 12 or 52 weeks. Acetone solvent treatment was begun at Week 13 in the group treated 12 weeks with TPA. At Week 16, the papilloma incidence was identical in the two groups of mice. However, by Week 28, the papilloma yield in the continuous TPA group had increased and was twice that of the acetone group, in which papillomas had regressed. The first carcinoma arose 14 weeks earlier with continuous TPA, but the final number of carcinomas per group of 40 mice was 17 with TPA and 20 with acetone. Neither the increase in papillomas in TPA-treated mice nor the regression of papillomas after cessation of promotion with TPA affected the final carcinoma yield. This result suggests that TPA-dependent papillomas are very unlikely to progress to carcinomas. In a third experiment, promotion of initiated SENCAR mice with mezerein resulted in a small number of papillomas which had a much higher probability of progression to carcinomas than the large number of papillomas promoted by TPA. The ability to induce papillomas with a known probability of conversion to carcinomas will facilitate the identification of markers associated with malignant progression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Shukla, Y. Ho, X. Liu, A. Ryscavage, and A. B. Glick Cripto-1 Alters Keratinocyte Differentiation via Blockade of Transforming Growth Factor-{beta}1 Signaling: Role in Skin Carcinogenesis Mol. Cancer Res., March 1, 2008; 6(3): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wei, S. Ku, G. K. Ma, S. Saito, A. A. Tang, J. Zhang, J.-H. Mao, E. Appella, A. Balmain, and E. J. Huang HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis PNAS, August 7, 2007; 104(32): 13040 - 13045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Millan, D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Perez-Sala, J. M. Rojas, A. Cano, and L. Bosca Potentiation of tumor formation by topical administration of 15-deoxy-{Delta}12,14-prostaglandin J2 in a model of skin carcinogenesis Carcinogenesis, February 1, 2006; 27(2): 328 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Woodworth, E. Michael, L. Smith, K. Vijayachandra, A. Glick, H. Hennings, and S. H. Yuspa Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte Carcinogenesis, September 1, 2004; 25(9): 1771 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Mao, M. D. To, J. Perez-Losada, D. Wu, R. Del Rosario, and A. Balmain Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression Genes & Dev., August 1, 2004; 18(15): 1800 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mittal, C. A. Elmets, and S. K. Katiyar Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation Carcinogenesis, August 1, 2003; 24(8): 1379 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Weinberg and M. F. Denning P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 453 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Divi, Y. P. Dragan, H. C. Pitot, and M. C. Poirier Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen Carcinogenesis, October 1, 2001; 22(10): 1693 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Coghlan, I. Gimenez-Conti, H. E. Kleiner, S. M. Fischer, J. E. Rundhaug, C. J. Conti, T. J. Slaga, and J. DiGiovanni Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis Carcinogenesis, April 1, 2000; 21(4): 641 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. I. Topley, R. Okuyama, J. G. Gonzales, C. Conti, and G. P. Dotto p21WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential PNAS, August 3, 1999; 96(16): 9089 - 9094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Arbeit, R. R. Riley, B. Huey, C. Porter, G. Kelloff, R. Lubet, J. M. Ward, and D. Pinkel Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice Cancer Res., August 1, 1999; 59(15): 3610 - 3620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A B Glick, M M Lee, N Darwiche, A B Kulkarni, S Karlsson, and S H Yuspa Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes & Dev., October 15, 1994; 8(20): 2429 - 2440. [Abstract] [PDF]
|
|
|
|
 |
|
 C.J. Kemp, P.A. Burns, K. Brown, H. Nagase, and A. Balmain Transgenic Approaches to the Analysis of ras and p53 Function in Multistage Carcinogenesis Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 427 - 434. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. Husain, Q. Yang, and D. K. Biswas cHa-ras Proto-oncogene: Amplification and Overexpression in UV-B-Induced Mouse Skin Papillomas and Carcinomas Arch Dermatol, March 1, 1990; 126(3): 324 - 330. [Abstract] [PDF]
|
|
|
|
|
|
A. W. Lin and S. W. Lowe Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation PNAS, April 24, 2001; 98(9): 5025 - 5030. [Abstract] [Full Text] [PDF]
|
|